Received Aug 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
did not receive 2nd dose yet; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a female patient who did not receive HBV (Engerix B) for prophylaxis. Previously administered products included Engerix B (Engerix-B got the first one back in November 2024 with batch no. MD9SL and expiry date 8th December 2026). The patient did not receive the 2nd dose of Engerix B, the patient experienced incomplete course of vaccination (Verbatim: did not receive 2nd dose yet). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 30-JUL-2025 A Health Care Provider wanted to know how to proceed with a patient that wants to receive the second dose of Engerix-B after getting the first one back in November 2024. Till the time of reporting patient did not receive 2nd dose of Engerix B which led to incomplete course of vaccination.